BioWorld Asia

July 6, 2006

View Archived Issues

Nicotine Receptor Discovery Could Help Treat Addiction

Diatos IPO Would Raise €25M, Sell Quarter Of Firm To Public

No Abstract Read More

Negative European Opinion Given For New Biogeneric

MediGene Shares Slide On FDA PDUFA Date Extension

New Institute Being Built To Focus On Oxford Research

Vectura Gets £45M, Reports Trial Data For Two Products

Cellectis, Bayer CropScience Working On Plant Technology

Other News To Note

Medivir Could Earn $111M Through New Tibotec Deals

Medivir AB could earn about $111 million in up-front and milestone payments from two new drug development licensing deals with Tibotec Pharmaceuticals Ltd. (BioWorld International) Read More

Unable To Attract Funding, TeGenero Going Belly Up

Today's news in brief

BioWorld

BioWorld briefs for Dec. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 29, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...